Lite Strategy, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Lite Strategy, Inc. (LITS) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $15.10 million for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $5.10M.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $4.96M, a 0.90% decline year-over-year.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $5.04M.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$40.00K, a 237.93% decline year-over-year.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$10.08M, a 201.05% decline from fiscal 2016.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $9.97M.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$10.06M.
- Lite Strategy, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$35.07M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 160 month |
|---|---|---|---|---|---|
| 2018-03-31 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $10.06M derived: sum of 2 quarters · filed 2018-05-09 | $15.10M 10-Q · filed 2018-05-09 | $15.06M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-12-31 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $10.01M 10-Q · filed 2018-02-08 | $9.96M derived: sum of 3 quarters · filed 2018-02-08 | $4.95M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-09-30 | $5.04M 10-Q · filed 2017-11-08 | $5.00M derived: sum of 2 quarters · filed 2017-11-08 | -$10.00K derived: sum of 3 quarters · filed 2018-05-09 | $5.00M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-06-30 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | -$5.05M derived: sum of 2 quarters · filed 2018-05-09 | -$44.00K derived: sum of 3 quarters · filed 2018-05-09 | -$10.08M 10-K · filed 2017-09-05 | |
| 2017-03-31 | -$5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$4.00K derived: sum of 2 quarters · filed 2018-05-09 | -$10.04M 10-Q · filed 2018-05-09 | -$10.01M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$5.03M 10-Q · filed 2018-02-08 | -$5.00M derived: sum of 3 quarters · filed 2018-02-08 | $6.00K derived: sum of 4 quarters · filed 2018-02-08 | |
| 2016-09-30 | -$10.03M 10-Q · filed 2017-11-08 | -$10.00M derived: sum of 2 quarters · filed 2017-11-08 | -$5.00M derived: sum of 3 quarters · filed 2017-11-08 | -$4.98M derived: sum of 4 quarters · filed 2017-11-08 | |
| 2016-06-30 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $5.03M derived: sum of 2 quarters · filed 2017-09-05 | $5.06M derived: sum of 3 quarters · filed 2017-09-05 | $9.97M 10-K · filed 2017-09-05 | |
| 2016-03-31 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-04 | $5.03M derived: sum of 2 quarters · filed 2017-05-04 | $9.94M 10-Q · filed 2017-05-04 | $14.94M derived: sum of 4 quarters · filed 2017-09-05 | |
| 2015-12-31 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $4.94M 10-Q · filed 2017-02-08 | $9.94M derived: sum of 3 quarters · filed 2017-09-05 | $14.93M derived: sum of 4 quarters · filed 2017-09-05 | |
| 2015-09-30 | $4.92M 10-Q · filed 2016-11-09 | $9.91M derived: sum of 2 quarters · filed 2017-09-05 | $14.90M derived: sum of 3 quarters · filed 2017-09-05 | -$15.14M derived: sum of 4 quarters · filed 2017-09-05 | |
| 2015-06-30 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-05 | $9.99M derived: sum of 2 quarters · filed 2017-09-05 | -$20.05M derived: sum of 3 quarters · filed 2017-09-05 | -$10.06M 10-K · filed 2017-09-05 | |
| 2015-03-31 | $4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-05 | -$25.05M derived: sum of 2 quarters · filed 2016-05-05 | -$15.05M 10-Q · filed 2016-05-05 | -$15.09M derived: sum of 4 quarters · filed 2016-09-06 | |
| 2014-12-31 | -$30.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | -$20.05M 10-Q · filed 2016-02-05 | -$20.08M derived: sum of 3 quarters · filed 2016-09-06 | -$35.10M derived: sum of 4 quarters · filed 2016-09-06 | |
| 2014-09-30 | $9.99M 10-Q · filed 2015-11-06 | $9.96M derived: sum of 2 quarters · filed 2016-09-06 | -$5.07M derived: sum of 3 quarters · filed 2016-09-06 | -$25.07M derived: sum of 4 quarters · filed 2016-09-06 | |
| 2014-06-30 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-06 | -$15.06M derived: sum of 2 quarters · filed 2016-09-06 | -$35.06M derived: sum of 3 quarters · filed 2016-09-06 | -$35.07M 10-K · filed 2016-09-06 | |
| 2014-03-31 | -$15.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-07 | -$35.02M derived: sum of 2 quarters · filed 2015-05-07 | -$35.03M 10-Q · filed 2015-05-07 | -$35.04M derived: sum of 4 quarters · filed 2015-09-02 | -$35.12M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | -$20.01M 10-Q · filed 2015-02-06 | -$20.02M derived: sum of 3 quarters · filed 2015-09-02 | ||
| 2013-09-30 | -$6.00K 10-Q · filed 2014-11-06 | -$16.00K derived: sum of 2 quarters · filed 2015-09-02 | |||
| 2013-06-30 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-02 | -$38.00K 10-K · filed 2015-09-02 | |||
| 2013-03-31 | -$28.00K 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |